Related Experiment Video

Updated: Feb 27, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K

Vaccine-associated paralytic poliomyelitis

M A Burgess1, P B McIntyre

  • 1National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Royal Alexandra Hospital for Children, Westmead, New South Wales.

Communicable Diseases Intelligence
|May 14, 1999
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.3K
Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

16.0K

Related Experiment Videos

Last Updated: Feb 27, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.3K
Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

16.0K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

33.3K
Overview
33.3K
Vaccinations01:51

Vaccinations

52.3K
Overview
52.3K

Articles linked to this work by shared authors, journal, and citation graph.

ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.

ESMO rare cancers·2026

Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia's childhood immunisation program.

International journal of population data science·2020

Q fever seroprevalence in Australia suggests one in twenty people have been exposed.

Epidemiology and infection·2020

Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.

Vaccine·2018

Varicella vaccine in non-immune household contacts of children with cancer or leukaemia.

Journal of paediatrics and child health·2017

Reconstructing larval growth and habitat use in an amphidromous goby using otolith increments and microchemistry.

Journal of fish biology·2016

Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.

Communicable diseases intelligence·2002

A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3.

Communicable diseases intelligence·2001

Onshore catering increases the risk of diarrhoeal illness amongst cruise ship passengers.

Communicable diseases intelligence·2001

Varicella vaccine in post-exposure prophylaxis.

Communicable diseases intelligence·2001

Measles outbreak among young adults in Victoria.

Communicable diseases intelligence·2001

Tuberculosis notifications in Australia, 1998.

Communicable diseases intelligence·2001

Comparison of cognitive function, depression, fall-related behaviors, and quality of life in elderly individuals according to age.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Prognostic Factors for Postictal Agitation After Electroconvulsive Therapy in Older Adults With Depression.

Acta psychiatrica Scandinavica·2026

'The soul has no disability': inclusion of people with disabilities in rural South Africa.

Rural and remote health·2026

Handgrip strength in children, adolescents, and young adults with suspected myalgic encephalomyelitis/chronic fatigue syndrome.

Journal of translational medicine·2026

Changes in frailty, depression and loneliness among stroke survivors and their spouses.

Cerebrovascular diseases (Basel, Switzerland)·2026

A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.

Journal of comparative effectiveness research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us